• Title/Summary/Keyword: obesity

Search Result 5,840, Processing Time 0.035 seconds

Adolescents' health behaviors and obesity: Does race affect this epidemic?

  • Dodor, Bernice A.;Shelley, Mack C.;Hausafus, Cheryl O.
    • Nutrition Research and Practice
    • /
    • v.4 no.6
    • /
    • pp.528-534
    • /
    • 2010
  • This study explores the influence of health behaviors and individual attributes on adolescent overweight and obesity using data from Wave II (Add Health). Structural equation model/ path analysis using maximum likelihood estimation was utilized to analyze the relationships of health behaviors and attributes with obesity. Results of the model reveal that the causal paths (adolescents' attributes and health behaviors) for overweight and obesity were different for African American and Caucasian adolescents. Generally, African Americans were more susceptible to overweight and obesity than Caucasians. Although increasing levels of vigorous physical activities lowers the risk for obesity among African American and Caucasian adolescents alike, low family SES and being sedentary were associated with overweight and obesity among Caucasians. No significant associations were found among African Americans. Increased hours of sleep at night relate positively with obesity among African Americans. These findings suggest important elements in the consideration of race in developing effective intervention and prevention approaches for curbing the obesity epidemic among U.S. adolescents.

The Health-related Quality of Life of Obesity (비만과 건강관련 삶의 질)

  • Kwon, Young-Dal
    • Journal of Korean Medicine for Obesity Research
    • /
    • v.4 no.1
    • /
    • pp.125-137
    • /
    • 2004
  • Objective: The purpose of this study is to investigate how to use the Quality of Life(QoL) of obesity and to study the report cases which measure QoL on obesity. Method: This study investigate the definition of Health-related Quality of Life(HRQoL), the measurement of Health-related Quality of Life, and the papers of Health-related Quality of Life on obesity through the books and medicine journals of HRQoL and obesity. Conclusions: 1. The QoL includes role functional ability, the degree and quality of social and community interaction, psychological state, somatic feeling, and life satisfaction than personal health and social well-being. 2. The investigator needs to evaluate the reliability, validity and sensitivity of the scale, and the appropriateness of the instrument for the target population When he decides measurement. 3. The investigator have the well-drilled supporter or himself managed the data and study population to prevent missing data. 4. The investigator should decide which is needed on obesity a obesity-specific or broad-ranging instrument, or both.

  • PDF

Recent Advances in Anti-Obesity Agents (비만 약물 치료의 최신 지견)

  • Kim, Min Kyung;Kim, Chul Sik
    • The Korean Journal of Medicine
    • /
    • v.93 no.6
    • /
    • pp.501-508
    • /
    • 2018
  • Obesity is a chronic disorder that is a significant risk factor for diabetes, cardiovascular diseases, malignancy, and other chronic diseases. Lifestyle modifications form the basis of most treatments for obesity, but it has become clear that such modifications alone are not enough for many obese patients. When a behavioral approach is insufficient, pharmacological treatment may be recommended. In recent years, the US Food and Drug Administration (FDA) has withdrawn several therapeutic options for obesity due to their side effects, but has approved four novel anti-obesity agents. Until recently, orlistat was the only drug approved for the management of long-term obesity, but the US FDA approved the novel anti-obesity drugs lorcaserin and phentermine/topiramate in 2012, and naltrexone/bupropion and liraglutide in 2014. The present review discusses the different pharmacotherapeutic options for the treatment of obesity.

Review on Studies of Wild Ginseng Complex Pharmacopuncture Related to Obesity Treatment (비만치료와 관련된 산삼복합약침요법에 대한 연구 동향 고찰)

  • Park, Jung-Sik
    • Journal of Korean Medicine for Obesity Research
    • /
    • v.21 no.1
    • /
    • pp.42-48
    • /
    • 2021
  • Objectives: The purpose of this study was to review the studies of the wild ginseng complex pharmacopuncture related to obesity treatment. Methods: We searched the papers with key words of 'wild ginseng complex pharmacopuncture', 'wild ginseng pharmacopuncture', 'obesity', 'fat', 'weight' in Oriental medicine Advanced Searching Integrated System, KRpia, Koreanstudies Information Service System, Research Information Sharing Service, KoreaMed and PubMed, Scopus. We classified the papers by year, content and study type. Results: There were 7 studies about the wild ginseng pharmacopuncture related to obesity treatment. Cell studies were excluded because they were not related to obesity. Analysis of 3 animal experiments and 4 clinical studies were conducted to describe each research subject, method, and research results. Conclusion: More interest and further research will be needed on wild ginseng pharmacopuncture related to obesity treatment in the Korean medicine to achieve clinical application and to develop treatment protocols for the obesity disease.

Two Cases of Obesity Treatment Using Liraglutide 3 mg with Intensive Behavioral Changes in Morbidly Obese Patients with Major Depressive Disorder (주요우울증을 동반한 고도비만 환자에 대한 행동요법을 병행한 리라글루티드 치료의 2예)

  • Ko, Hae-Jin
    • Archives of Obesity and Metabolism
    • /
    • v.1 no.1
    • /
    • pp.39-42
    • /
    • 2022
  • Obesity is a chronic disease associated with severe complications. A major complication of obesity is depression, which can worsen obesity and vice versa. In addition, most antidepressants or antipsychotics cause weight gain, and the relationship between obesity and depression is clinically critical. However, treatment of obese patients with major depressive disorder is complicated. Bariatric physicians should provide appropriate behavioral interventions alongside pharmacological treatment, considering psychiatric symptoms, drug side effects, and drug interactions. Two successful cases of moderate-to-severe obese patients with major depressive disorder who had been treated for obesity using behavioral intervention therapy along with liraglutide will be discussed. This report highlights the safety and efficacy of liraglutide treatment of obesity in patients with depression who take antidepressants and antipsychotics.

Effects of Exercise on Cardiovascular Disease Risk Factors in Sarcopenic Obesity Elderly Women (규칙적인 운동이 sarcopenic 비만여성고령자의 심혈관질환 위험인자에 미치는 영향)

  • Jung, Joo-Ha;Yang, Seung-Jai
    • Journal of the Korea Academia-Industrial cooperation Society
    • /
    • v.13 no.9
    • /
    • pp.3962-3972
    • /
    • 2012
  • The purpose of this study was to analyze the effects of combined exercise on body composition and cardiovascular disease risk factors in sarcopenic obesity elderly women. The subjects for the study were 21 obesity elderly women over 65 years old. They were divided into two groups, the sarcopenic obesity group(n=9) and non-sarcopenic obesity group(n=12). The variables of body composition and CVD risk factors were measured in all the subjects before and after 16-week combined exercise. The findings of this study were as follows; In the sarcopenic obesity elderly women significantly decreased total cholesterol(TC), triglyceride(TG), and left baPWV. The non-sarcopenic obesity elderly women significantly decreased total cholesterol(TC), triglyceride(TG), low density lipoprotein-cholesterol (LDL-C), and left baPWV, but significantly increased high density lipoprotein-cholesterol(HDL-C). The most important finding in this study was that sarcopenic obesity elderly women showed delayed effects of a 16-week combined exercise on HDL, LDL-C, BP, and right baPWV compared to the non-sarcopenic obesity elderly women.

Development of a Web-Based Obesity Management Program for Elementary School Students (초등학생을 위한 웹기반 비만관리 프로그램 개발)

  • Lee, Hae Sun;Park, Jeong Sook
    • The Journal of Korean Academic Society of Nursing Education
    • /
    • v.19 no.2
    • /
    • pp.215-227
    • /
    • 2013
  • Purpose: The purpose of this study is to develop a 12-week web-based obesity management program for elementary school students and to evaluate the appropriateness of the developed program from experts and users. Methods: The development of a web-based obesity management program proceeded through the stages of analysis, design, development, and evaluation. After the application of the web-based obesity management program, the evaluation of appropriateness were conducted for knowledge of obesity, obesity control behavior and satisfaction of the program. Collected data has been analyzed using SPSS 19.0. Results: The name of the program developed by this study is healthful weight management and its URL is http://ihealth.or.kr. There were 6 major menus and 18 sub menus including diet, exercise and behavior modification in this program. This study showed that this web-based obesity management program had high satisfaction for a system and increase knowledge of obesity and obesity control behavior for obese children. Conclusion: We expect the web-based obesity management program for elementary school students developed by this study will be able to lead the practice and participation of obese children and decrease the degree of obesity.

Analysis of Anthropometric Measuremetnts, Eating Habits, and Dietary Intake of Women with Child-bearing Experiences and Different Body Fat Contents (비만도가 다른 출산경험여성의 신체계측, 식습관 및 영양소섭취상태 연구)

  • 유윤희
    • Journal of Nutrition and Health
    • /
    • v.30 no.2
    • /
    • pp.201-209
    • /
    • 1997
  • The purpose of this study was to investigate the possible causal factors of obesity in women with child-bearing experiences in effects to provide optimal information for the prevention and/or treatment of obesity. Sventy one women with child-bearing experiences were divided into five groups based on the degree of obesity by BROCA method ; normal weight, overweight, and obesity which was further divided into three groups of light, moderate, and sever obesity. Various anthropomnetric measurements, overall eating habits, and dietery intakes were asessed for each groups. Out of eighteen anthropometric factors asociated with obesity, thirteen measurements were represented to be valid for the diagnosis of obesity. Body fat % which was analyzed by Bioelectrical Impedance fatnee Analyzer were 24.765, 28.05%, and 29.85 for normal, overweight, and obesity group respectively. WHR(waister to hip ratio) or BMI(body mass index) widely used index was also resulted to be valid as a predictor of obesity. Waist circumference which represents abdominal fat mass showed a good correlatin with body fat%. The analysis of dietary intakes suggested that the overintakes of total calorie may not be the only causal factor of obesity, rather the amount of daily protein, fat and carbohydrate intakes or the physical activity level would be more closely related with the prevalence of obesity. Further investigation considering more variety of food composition of diet and the activity level involving larger number of subjects would be needed.

  • PDF

Obesity, obesity-related diseases and application of animal model in obesity research An overview

  • Park, Byung-Sung;Singh, N.K.;Reza, A.M.M.T.
    • Journal of the Korean Applied Science and Technology
    • /
    • v.30 no.4
    • /
    • pp.622-634
    • /
    • 2013
  • The multi-origin of obesity and its associated diseases made it's a complex area of biomedical science research and severe health disorder. From the 1970s to onwards this health problem turned to an epidemic without having any report of declining yet and it created a red alert to the health sector. Meanwhile, many animal models have been developed to study the lethal effect of obesity. In consequence, many drugs, therapies and strategies have already been adopted based on the findings of those animal models. However, many complicated things based on molecular and generic mechanism has not been clarified to the date. Thus, it is important to develop a need based animal model for the better understanding and strategic planning to eliminate/avoid the obesity disorder. Therefore, the present review would unveil the pros and cons of presently established animal models for obesity research. In addition, it would indicate the required turning direction for further obesity and obesity based disease research.

Anti-Obesity Drugs: A Current Research Insight

  • Son Eun-hwa;In San-Whan;Kim Byung-Oh;Pyo Suhkneung
    • Biomedical Science Letters
    • /
    • v.11 no.2
    • /
    • pp.89-101
    • /
    • 2005
  • Obesity is increasing worldwide and has become a major health burden in Western societies affecting every third American and every fifth European. Obesity makes a major contribution to morbidity and mortality, predisposing individuals to cardiovascular disease and diabetes. Many new substances are currently being investigated for their usefulness in the pharmacotherapy of obesity. Most anti-obesity drugs can be divided into four groups: those that reduce food intake; those that alter metabolism; those that increase thermogenesis; and those that regulate hormone involved in feeding behavior. In this article we review these and other agents available in various countries for the treatment of obesity. Perhaps more importantly, we have focussed on areas of potential productivity in the future. Over the last 5 or so years, this impetus in obesity research has provided us with exciting new drugs targets involved in the regulation of feeding behavior and cellular mechanism involved in energy expenditure. Recent development in the quest for control of human obesity include the discovery of hormones, neuropeptides, receptors and transcription factors involved in feeding behavior, metabolic rate and adipocyte development. For developing new, perhaps even more specific pharmacological agents, further research is needed to understand the individual different genetic and physiological basis of obesity. It remains the hope of research scientists that in the not too distant future we shall see a new class of anti-obesity drugs arising logically from the molecular biology revolutions.

  • PDF